Company Valuation 101 - Question, page-17

This stock will have its day of reckoning sooner or later when the rug gets pulled from underneath it. The share price could more than halve from current valuation and it still wouldn't be remotely close to "fair" value on any logical metric.

Comparing this to A2M is fraught with danger. A2M has a product that literally flies off shelves. WHA sells next to nothing relatively speaking. A2M also has the benefit of having a point of differentiation. What point of differentiation does WHA infant formula have? It's just another generic formula. CFDA is not a ticket to riches. You still need to have a product that sells.

This one takes the award for most overvalued stock. Its competition have all bit the dust recently with their day of reckoning, namely, MUS, RAP and IAM

This one gets the inaugural Certified Turd award